Genocea Biosciences, Inc.
GNCADelisted Jun 2, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001457612
Genocea Biosciences, Inc. was delisted on Jun 2, 2022; its insiders filed their last Form 4 on Jun 3, 2022; 40 institutions reported holding it in 13F filings for Q1 2022, worth $42.1M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Genocea Biosciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
GNCA is no longer listed, so this page shows Q1 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 40
- −1 vs. Q4 2021
- Shares held
- 33.6M
- +112.9K (+0.3%) vs. Q4 2021
- Total value
- $42.1M
- +$3.16M (+8.1%) vs. Q4 2021
- New holders
- 3
- 11 more added
- Sold out
- 4
- 7 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $1 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $4.00K |
| Q2 2022 | 5 | $92.0K |
| Q1 2022 | 40 | $42.1M |
| Q4 2021 | 41 | $38.9M |
| Q3 2021 | 40 | $65.3M |
| Q2 2021 | 46 | $79.4M |
| Q1 2021 | 42 | $86.3M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Genocea Biosciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 10,376,936 | $13.0M | 0.42% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 5,084,184 | $6.36M | 0.12% | 00.0% | Unchanged |
| BVF Inc | 4,012,404 | $5.02M | 0.20% | 00.0% | Unchanged |
| Commodore Capital LP | 3,079,756 | $3.85M | 0.86% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,576,385 | $3.22M | 0.01% | −76,589−2.9% | Reduced |
| Kingdon Capital Management, L.L.C. | 1,972,056 | $2.46M | 0.42% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,843,112 | $2.30M | 0.00% | +47,617+2.7% | Added |
| Vanguard Group Inc | 1,574,979 | $1.97M | 0.00% | +1000.0% | Added |
| Boxer Capital, LLC | 1,134,453 | $1.42M | 0.07% | 00.0% | Unchanged |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $469.0K | 32.06% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 291,733 | $364.0K | 0.00% | +84,853+41.0% | Added |
| Millennium Management LLC | 215,002 | $269.0K | 0.00% | +18,569+9.5% | Added |
| HighTower Advisors, LLC | 212,260 | $266.0K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 206,336 | $259.0K | 0.08% | +9,515+4.8% | Added |
| BlackRock Inc. | 180,367 | $225.0K | 0.00% | −5,076−2.7% | Reduced |
| Northern Trust Corp | 70,837 | $89.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 57,363 | $72.0K | 0.00% | −270.0% | Reduced |
| Group One Trading, L.P. | 50,517 | $63.0K | 0.00% | +6,503+14.8% | Added |
| Renaissance Technologies LLC | 42,700 | $53.0K | 0.00% | +15,200+55.3% | Added |
| Commonwealth Equity Services, LLC | 40,069 | $50.0K | 0.00% | +8,088+25.3% | Added |
| BIT Capital GmbH | 35,000 | $43.8K | 0.00% | +35,000 | New |
| Morgan Stanley | 28,163 | $35.0K | 0.00% | +14,527+106.5% | Added |
| State Street Corp | 24,384 | $30.0K | 0.00% | +4,700+23.9% | Added |
| Boothbay Fund Management, LLC | 19,916 | $25.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 18,433 | $23.0K | 0.00% | +18,433 | New |
| Bank of New York Mellon Corp | 16,305 | $20.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 16,463 | $20.0K | 0.00% | +7,001+74.0% | Added |
| Personal Capital Advisors Corp | 15,000 | $19.0K | 0.00% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 15,000 | $18.0K | 0.01% | 00.0% | Unchanged |
| Capital Asset Advisory Services LLC | 11,766 | $15.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 10,000 | $13.0K | 0.00% | −12,677−55.9% | Reduced |
| Empirical Asset Management, LLC | 10,000 | $13.0K | 0.01% | 00.0% | Unchanged |
| Simplex Trading, LLC | 8,976 | $11.0K | 0.00% | −22,039−71.1% | Reduced |
| Tower Research Capital LLC (TRC) | 5,847 | $7.00K | 0.00% | −211−3.5% | Reduced |
| ACT Capital Management, LLC | 5,000 | $6.00K | 0.01% | 00.0% | Unchanged |
| First Manhattan Co | 2,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 905 | $1.00K | 0.00% | −132−12.7% | Reduced |
| Cutler Group LP | 900 | $1.00K | 0.00% | 00.0% | Unchanged |
| Artemis Wealth Advisors, LLC | 1,137 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 900 | $1.00K | 0.00% | +900 | New |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −21,741−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,503−100.0% | Sold out |
| Vectors Research Management, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,129−100.0% | Sold out |